| Daniel Aaron Goodman, MD | |
|
355 E Erie St, Chicago, IL 60611-3167 | |
| (312) 238-1000 | |
| (312) 238-3695 |
| Full Name | Daniel Aaron Goodman |
|---|---|
| Gender | Male |
| Speciality | Physical Medicine And Rehabilitation |
| Experience | 12 Years |
| Location | 355 E Erie St, Chicago, Illinois |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1699041657 | NPI | - | NPPES |
| 036140366-1 | Medicaid | IL | |
| P01789510 | Other | IL | RAILROAD MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208100000X | Physical Medicine & Rehabilitation | 036-140366 (Illinois) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Northwestern Memorial Hospital | Chicago, IL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Medical Services Ric | 4880598978 | 85 |
News Archive
Common practice, and recently published research, shows that the risk of complications with surgery increases in very old or frail adults including those with heart failure.
Artisan Pharma, Inc., a private biopharmaceutical company dedicated to bringing best-in-class critical care therapeutics to patients, today announced the completion of patient enrollment in its Phase 2b study of ART-123 (Recomodulin® - recombinant human thrombomodulin) in sepsis patients with disseminated intravascular coagulation (DIC). The clinical trial was a randomized, double-blind, placebo-controlled Phase 2b study to assess the safety and efficacy of ART-123 in patients with sepsis and DIC.
The North American Thrombosis Forum (NATF), in coordination with Eisai Inc., announced today that three hospitals have been selected as recipients of the 2009 DVTeamCare Hospital Award. This new award was established by Eisai to recognize hospitals that have made a significant commitment to preventing deep vein thrombosis (DVT) and its potentially fatal complications, including pulmonary embolism (PE).
A mini-sling that requires a single incision may be a viable alternative to the "gold standard" transobturator midurethral sling for the treatment of stress urinary incontinence, a randomised controlled trial has found.
For women in their 30s and beyond, the probability of a pregnancy that results in a miscarriage or a Down syndrome pregnancy is staggering with the risk increasing to 1 in 3 by the time a woman reaches her early 40s due to the "maternal age effect," the high incidence of mistakes in chromosome segregation that occur during the cell division process of meiosis, which gives rise to the egg.
› Verified 7 days ago
| Entity Name | University Of Chicago |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1821048786 PECOS PAC ID: 7719899426 Enrollment ID: O20031103000094 |
News Archive
Common practice, and recently published research, shows that the risk of complications with surgery increases in very old or frail adults including those with heart failure.
Artisan Pharma, Inc., a private biopharmaceutical company dedicated to bringing best-in-class critical care therapeutics to patients, today announced the completion of patient enrollment in its Phase 2b study of ART-123 (Recomodulin® - recombinant human thrombomodulin) in sepsis patients with disseminated intravascular coagulation (DIC). The clinical trial was a randomized, double-blind, placebo-controlled Phase 2b study to assess the safety and efficacy of ART-123 in patients with sepsis and DIC.
The North American Thrombosis Forum (NATF), in coordination with Eisai Inc., announced today that three hospitals have been selected as recipients of the 2009 DVTeamCare Hospital Award. This new award was established by Eisai to recognize hospitals that have made a significant commitment to preventing deep vein thrombosis (DVT) and its potentially fatal complications, including pulmonary embolism (PE).
A mini-sling that requires a single incision may be a viable alternative to the "gold standard" transobturator midurethral sling for the treatment of stress urinary incontinence, a randomised controlled trial has found.
For women in their 30s and beyond, the probability of a pregnancy that results in a miscarriage or a Down syndrome pregnancy is staggering with the risk increasing to 1 in 3 by the time a woman reaches her early 40s due to the "maternal age effect," the high incidence of mistakes in chromosome segregation that occur during the cell division process of meiosis, which gives rise to the egg.
› Verified 7 days ago
| Entity Name | The University Of Chicago Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033218128 PECOS PAC ID: 7618880766 Enrollment ID: O20031106000203 |
News Archive
Common practice, and recently published research, shows that the risk of complications with surgery increases in very old or frail adults including those with heart failure.
Artisan Pharma, Inc., a private biopharmaceutical company dedicated to bringing best-in-class critical care therapeutics to patients, today announced the completion of patient enrollment in its Phase 2b study of ART-123 (Recomodulin® - recombinant human thrombomodulin) in sepsis patients with disseminated intravascular coagulation (DIC). The clinical trial was a randomized, double-blind, placebo-controlled Phase 2b study to assess the safety and efficacy of ART-123 in patients with sepsis and DIC.
The North American Thrombosis Forum (NATF), in coordination with Eisai Inc., announced today that three hospitals have been selected as recipients of the 2009 DVTeamCare Hospital Award. This new award was established by Eisai to recognize hospitals that have made a significant commitment to preventing deep vein thrombosis (DVT) and its potentially fatal complications, including pulmonary embolism (PE).
A mini-sling that requires a single incision may be a viable alternative to the "gold standard" transobturator midurethral sling for the treatment of stress urinary incontinence, a randomised controlled trial has found.
For women in their 30s and beyond, the probability of a pregnancy that results in a miscarriage or a Down syndrome pregnancy is staggering with the risk increasing to 1 in 3 by the time a woman reaches her early 40s due to the "maternal age effect," the high incidence of mistakes in chromosome segregation that occur during the cell division process of meiosis, which gives rise to the egg.
› Verified 7 days ago
| Entity Name | Medical Services Ric |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1659306587 PECOS PAC ID: 4880598978 Enrollment ID: O20040106000335 |
News Archive
Common practice, and recently published research, shows that the risk of complications with surgery increases in very old or frail adults including those with heart failure.
Artisan Pharma, Inc., a private biopharmaceutical company dedicated to bringing best-in-class critical care therapeutics to patients, today announced the completion of patient enrollment in its Phase 2b study of ART-123 (Recomodulin® - recombinant human thrombomodulin) in sepsis patients with disseminated intravascular coagulation (DIC). The clinical trial was a randomized, double-blind, placebo-controlled Phase 2b study to assess the safety and efficacy of ART-123 in patients with sepsis and DIC.
The North American Thrombosis Forum (NATF), in coordination with Eisai Inc., announced today that three hospitals have been selected as recipients of the 2009 DVTeamCare Hospital Award. This new award was established by Eisai to recognize hospitals that have made a significant commitment to preventing deep vein thrombosis (DVT) and its potentially fatal complications, including pulmonary embolism (PE).
A mini-sling that requires a single incision may be a viable alternative to the "gold standard" transobturator midurethral sling for the treatment of stress urinary incontinence, a randomised controlled trial has found.
For women in their 30s and beyond, the probability of a pregnancy that results in a miscarriage or a Down syndrome pregnancy is staggering with the risk increasing to 1 in 3 by the time a woman reaches her early 40s due to the "maternal age effect," the high incidence of mistakes in chromosome segregation that occur during the cell division process of meiosis, which gives rise to the egg.
› Verified 7 days ago
| Entity Name | Rehabilitation Institute Of Chicago |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205879095 PECOS PAC ID: 0547255424 Enrollment ID: O20040727000121 |
News Archive
Common practice, and recently published research, shows that the risk of complications with surgery increases in very old or frail adults including those with heart failure.
Artisan Pharma, Inc., a private biopharmaceutical company dedicated to bringing best-in-class critical care therapeutics to patients, today announced the completion of patient enrollment in its Phase 2b study of ART-123 (Recomodulin® - recombinant human thrombomodulin) in sepsis patients with disseminated intravascular coagulation (DIC). The clinical trial was a randomized, double-blind, placebo-controlled Phase 2b study to assess the safety and efficacy of ART-123 in patients with sepsis and DIC.
The North American Thrombosis Forum (NATF), in coordination with Eisai Inc., announced today that three hospitals have been selected as recipients of the 2009 DVTeamCare Hospital Award. This new award was established by Eisai to recognize hospitals that have made a significant commitment to preventing deep vein thrombosis (DVT) and its potentially fatal complications, including pulmonary embolism (PE).
A mini-sling that requires a single incision may be a viable alternative to the "gold standard" transobturator midurethral sling for the treatment of stress urinary incontinence, a randomised controlled trial has found.
For women in their 30s and beyond, the probability of a pregnancy that results in a miscarriage or a Down syndrome pregnancy is staggering with the risk increasing to 1 in 3 by the time a woman reaches her early 40s due to the "maternal age effect," the high incidence of mistakes in chromosome segregation that occur during the cell division process of meiosis, which gives rise to the egg.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Daniel Aaron Goodman, MD 355 E Erie St, Chicago, IL 60611-3167 Ph: (312) 238-1000 | Daniel Aaron Goodman, MD 355 E Erie St, Chicago, IL 60611-3167 Ph: (312) 238-1000 |
News Archive
Common practice, and recently published research, shows that the risk of complications with surgery increases in very old or frail adults including those with heart failure.
Artisan Pharma, Inc., a private biopharmaceutical company dedicated to bringing best-in-class critical care therapeutics to patients, today announced the completion of patient enrollment in its Phase 2b study of ART-123 (Recomodulin® - recombinant human thrombomodulin) in sepsis patients with disseminated intravascular coagulation (DIC). The clinical trial was a randomized, double-blind, placebo-controlled Phase 2b study to assess the safety and efficacy of ART-123 in patients with sepsis and DIC.
The North American Thrombosis Forum (NATF), in coordination with Eisai Inc., announced today that three hospitals have been selected as recipients of the 2009 DVTeamCare Hospital Award. This new award was established by Eisai to recognize hospitals that have made a significant commitment to preventing deep vein thrombosis (DVT) and its potentially fatal complications, including pulmonary embolism (PE).
A mini-sling that requires a single incision may be a viable alternative to the "gold standard" transobturator midurethral sling for the treatment of stress urinary incontinence, a randomised controlled trial has found.
For women in their 30s and beyond, the probability of a pregnancy that results in a miscarriage or a Down syndrome pregnancy is staggering with the risk increasing to 1 in 3 by the time a woman reaches her early 40s due to the "maternal age effect," the high incidence of mistakes in chromosome segregation that occur during the cell division process of meiosis, which gives rise to the egg.
› Verified 7 days ago
Patrick Joseph Barrett, MD Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 345 E Superior St, 16th Floor, Chicago, IL 60611 Phone: 312-238-2780 | |
Dr. Monica E Rho, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 355 E Erie St, Chicago, IL 60611 Phone: 312-238-1000 Fax: 312-238-7709 | |
Ms. Shivani Dua, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 1725 W Harrison St Ste 885, Chicago, IL 60612 Phone: 312-942-2384 | |
Kara Eder, DPT Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 333 E Benton Pl Ste 108, Chicago, IL 60601 Phone: 312-929-3646 | |
Dr. Sonika Randev, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 401 N Michigan Ave Ste 1200, Chicago, IL 60611 Phone: 312-635-0973 | |
Lauren E Splittgerber, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 355 E Erie St, Chicago, IL 60611 Phone: 312-238-1000 Fax: 312-238-7767 | |
Reza Zayn Tanveer, Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 1620 W Harrison St, Chicago, IL 60612 Phone: 312-942-5000 |